Insider · CIK 0001945557
Joshua Schafer
Files at ZVRA (ZEVRA THERAPEUTICS, INC.). First filing Feb 2, 2026, latest Feb 4, 2026.
In brief
Joshua Schafer files SEC Form 4 as officer at ZVRA (ZEVRA THERAPEUTICS, INC.). Since Feb 2, 2026, Joshua Schafer has reported 0 open-market buys worth $0 and 2 open-market sells worth $126k, the latest filed on Feb 4, 2026.
A track record needs three past buys with six months of prices behind them; Joshua Schafer has 0, so none is measured yet.
The newest scored trade: sold $97k of ZVRA on Feb 3, 2026, filed Feb 4, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $126k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZVRA: ZEVRA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | ZEVRA THERAPEUTICS, INC. | $97k 10,500 shares | -14% | +40% from low-28% from high | |
| 0Weak | ZEVRA THERAPEUTICS, INC. | $30k 3,375 shares | -8% | +37% from low-30% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS INC | 13,875 0.02% of outstanding | $123k | Jan 30, 2026 | none |
| Feb 13, 2025 | ZVRA ZEVRA THERAPEUTICS INC | 10,500 0.20% of outstanding | $81k | Feb 13, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -10,500 | $9.19 | $97k | 62,278 | Feb 4, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,333 | - | - | 40,819 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,375 | $8.83 | $30k | 37,444 | Feb 2, 2026 |
| Jan 31, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +35,334 | - | - | 72,778 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitderivative10b5-1 | +37,500 | $0.00 | $0 | 37,500 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +75,000 | $0.00 | $0 | 75,000 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -11,333 | $0.00 | $0 | 22,667 | Feb 2, 2026 |
| Jan 31, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -35,334 | $0.00 | $0 | 35,333 | Feb 2, 2026 |
Questions about Joshua Schafer
Answered from the filings on this page, as of the latest one.
Is Joshua Schafer buying or selling?
In the last 12 months Joshua Schafer reported 0 open-market buys worth $0 and 2 open-market sells worth $126k on SEC Form 4; the latest was sold $97k of ZVRA on Feb 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Joshua Schafer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joshua Schafer has 0.
Where does Joshua Schafer file Form 4?
Joshua Schafer has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.) as CCO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.